Colorectal cancer screening - Methodology

Surgeon

Volumn 8, Issue 3, 2010, Pages 164-171

  Jenkinson, F ^a   Steele, R J C ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Colorectal cancer; DNA mutations; Faecal occult blood; Screening

Indexed keywords

COLORECTAL TUMOR; DIFFERENTIAL DIAGNOSIS; HUMAN; INCIDENCE; MASS SCREENING; METHODOLOGY; PRACTICE GUIDELINE; REVIEW; UNITED KINGDOM;

COLORECTAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; HUMANS; INCIDENCE; MASS SCREENING; PRACTICE GUIDELINES AS TOPIC; SCOTLAND;

EID: 77950863078     PISSN: 1479666X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surge.2009.10.015     Document Type: Review

References (50)

1. Scotland I.S.D. NHS National Services Scotland. http://www.isdscotland.org/isd/1425.html#Summary%20statistics%20for%20colorectal%20cancer [accessed 01.07.09]
2. Cancer research UK: cancerstats. http://info.cancerresearchuk.org/cancerstats/incidence [accessed 01.07.09]
3. Morson B. The polyp-cancer sequence in the large bowel. Proceedings of the Royal Society of Medicine 67 (1974) 451-457
4. Wilson J.M., and Jungner F. Principles and practice of screening for disease. Public health papers no. 34 (1968), WHO, Geneva
5. Leslie A., Carey F.A., Pratt N.R., and Steele R.J.C. The colorectal adenoma-carcinoma sequence. British Journal of Surgery 89 (2002) 845-860
6. Scottish Intercollegiate Guidelines Network. Guidelines on the management of colorectal cancer (2003), SIGN Guideline 67, Edinburgh
7. Benson V.S., Patnick J., Davies A.K., Nadel M.R., Smith R.A., Atkin W.S., and on behalf of the International Colorectal Cancer Screening Network. Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. International Journal of Cancer 122 (2008) 1357-1367
8. Walsh J.M.E., and Terdiman J.P. Colorectal cancer screening scientific review. JAMA 289 (2003) 1288-1296
9. Osborn N.K., and Ahlquist D.A. Stool screening for colorectal cancer: molecular approaches. Gastroenterology 128 (2005) 192-206
10. Levin B., Brooks D., Smith R., and Stone A. Emerging technologies in screening for colorectal cancer: ct colonography, immunochemical fecal occult blood tests and stool screening using molecular markers. CA Cancer Journal for Clinicians 53 (2003) 44-55
11. Hardcastle J.D., Chamberlain J.O., Robinson M.H.E., Moss S.M., Amar S.S., Balfour T.W., et al. Randomised controlled trial of faecal occult blood screening for colorectal cancer. Lancet 348 (1996) 1472-1477
12. Smith A., Young G.P., Cole S.R., and Bampton P. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer 107 (2006) 2152-2159
13. Fraser C.G., Mathew C.M., Mowat N.A.G., Wilson JA., Carey F.A., and Steele R.J.C. Evaluation of a card collection-based faecal immunochemical test in screening for colorectal cancer using two-tier reflex approach. Gut 56 (2007) 1415-1418
14. Imperiale T.F. Quantitative immunochemical fecal occult blood tests: is it time to go back to the future?. Annals of Internal Medicine 146 (2007) 309-311
15. Mandel J.S., Bond J.H., Church J.R., Snover D.C., Bradley G.M., Schuman L.M., et al. Reducing mortality from colorectal cancer by screening for faecal occult blood. New England Journal of Medicine 328 (1993) 1365-1371
16. Kronborg O., Fenger C., Olsen J., Jorgensen O.D., and Sondergaard O. Randomised study of screening for colorectal cancer with faecal occult blood test. Lancet 348 (1996) 1467-1471
17. Faivre J., Dancourt V., Lejeune C., Tazi M.A., Lamour J., Gerard D., et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology 126 (2004) 1674-1680
18. Towler B., Irwig L., Glasziou P., Kewenter J., Weller D., and Silagy C. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. BMJ 317 (1998) 559-565
19. Steele R., McClements P., Libby G., Black R., Morton C., Birrell J., et al. Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer. Gut 58 (2009) 530-535
20. UK Flexible Sigmoidoscopy Screening Trial Investigators. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomized trial. Lancet 359 (2002) 1291-1300
21. Segnan N., Senore C., Andreoni B., Aste H., Bonelli L., Crosta C., et al. Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy". Journal of National Cancer Institute 94 (2002) 1763-1772
22. Winawer S.J., Zauber A.G., Ho M.N., O'Brien M.J., Gottlieb L.S., Sternberg S.S., et al. Prevention of colorectal cancer by colonoscopic polypectomy. New England Journal of Medicine 329 (1993) 1977-1981
23. Lieberman D.A., Weiss D.G., Bond J.H., Ahnen D.J., Garewal H., and Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. New England Journal of Medicine 380 (2000) 162-168
24. Nicholson F.B., Barro J.L., Atkin W., Lilford R., Patnick J., Williams C.B., et al. Review article: population screening for colorectal cancer. Alimentary Pharmacol & Therapeutics 22 (2005) 1069-1077
25. Sun L., Wu H., and Guan Y. Colonography by CT, MRI, PET/CT combined with conventional colonoscopy in colorectal cancer screening and staging. World Journal of Gastroenterology 14 (2008) 853-863
26. Liedenbaum M., van Rijn A., de Vries A., Dekker H., Thomeer M., van Marrewijk C., et al. Using CT colonography as a triage technique after a positive faecal occult blood test in colorectal cancer screening. Gut 58 (2009) 1242-1249
27. Fernandez-Urien I., Carretero C., Borda A., and Munoz-Navas M. Colon capsule endoscopy. World Journal of Gastroenterology 14 (2008) 5265-5268
28. Deenadayalu V.P., and Rex D.K. Fecal-based DNA assays: a new, non-invasive approach to colorectal cancer screening. Cleveland Clinic Journal of Medicine 71 (2004) 497-503
29. Loganayagam A. Faecal screening of colorectal cancer. International Journal of Clinical Practice 62 (2008) 454-459
30. Smith G., Carey F.A., Beattie J., Wilkie M., Lightfoot T., and Coxhead J. Mutations in APC, Kirsten-ras and p53-alternative genetic pathways to colorectal cancer. Proceedings of the National Academy of Sciences 99 (2002) 9433-9438
31. Zhang W., Bauer M., Croner R.S., Pelz J.O.W., Lodygin D., Hermeking H., et al. DNA stool test for colorectal cancer: hypermethylation of the secrete frizzled-related protein-1 gene. Diseases of the Colon & Rectum 50 (2007) 1618-1626
32. Muller H.M., Oberwalder M., Fiegl H., Morandell M., Goebel G., Zitt M., et al. Methylation changes in faecal DNA: a marker for colorectal cancer screening. Lancet 262 (2004) 1283-1285
33. Whitney D., Skoletsky J., Moore K., Boynton K., Kann L., Brand R., et al. Enhanced retrieval of DNA from human fecal samples results in improved performance of colorectal cancer screening test. Journal of Molecular Diagnostics 6 (2004) 386-395
34. Houlston R.S. What we could do now: molecular pathology of colorectal cancer. Journal of Clinical Pathology: Molecular Pathology 54 (2001) 206-214
35. Kimura K., Nagasaka T., and Hoshizima N. No duplicate KRAS mutation is identified on the same allele in gastric or colorectal cancer cells with multiple KRAS mutations. Journal of International Medical Research 35 (2007) 450-457
36. Prix L., Uciechiwski P., Bockmann B., Giesing M., and Schuetz A.J. Diagnostic biochip array for fast and sensitive detection of K-ras mutations in stool. Clinical Chemistry 48 (2002) 428-435
37. Davies H., Bignell G.R., Cox C., Stephens P., Edkins S., Clegg S., et al. Mutations of the BRAF gene in human cancer. Nature 417 (2002) 949-954
38. Kadiyska T.K., Konstantinova D.V., Atanasov V.R., Kremensky I.M., and Mitev V.I. Frequency and application of the hot spot BRAF gene mutation (p. V600E) in the diagnostic strategy for hereditary nonpolyposis colorectal cancer. Cancer Detection and Prevention 31 (2007) 254-256
39. Traverso G., Shuber A., Levin B., Johnson C., Olsson L., Schoetz D.J., et al. Detection of APC mutations in fecal DNA from patients with colorectal tumors. New England Journal of Medicine 346 (2002) 311-320
40. Steele R.J., and Lane D.P. P53 in cancer: a paradigm for modern management of cancer. Surgeon 3 (2005) 197-205
41. Ahlquist D.A., Skoletsky J.E., Boynton K.A., Harrington J.J., Mahoney D.W., Pierceall W.E., et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 119 (2000) 1219-1227
42. Tagore K.S., Lawson M.J., Yucaitis J.A., Gage R., Orr T., Shuber A.P., et al. Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia. Clinical Colorectal Cancer 3 (2003) 47-53
43. Syngal S., Chung D., Willet C., and Schoetz D. Stool DNA analysis for the detection and follow-up of colorectal cancer (CRC) and advanced adenomas (AA): sensitivity in a prospective series. Gastroenterology 97 Suppl. 1 (2002) 332
44. Dong S.M., Traverso G., Johnson C., Geng L., Favis R., Boynton K., et al. Detecting colorectal cancer in stool with the use of multiple genetic targets. Journal of National Cancer Institute 93 (2001) 858-865
45. http://www.gene-chips.com [accessed 27.11.07]
46. Fitzgerald S.P., Lamont J.V., McConnell R.I., and BenchikhEl O. Development of a high-throughput automated analyzer using biochip array technology. Clinical Chemistry 51 (2005) 1165-1176
47. Haug U., Rothenbacher D., Wente M., Seiler C., Stegmaier C., and Brenner H. Tumour M2-PK as a stool marker for colorectal cancer: comparative analysis in a large sample of unselected older adults vs colorectal cancer patients. British Journal of Cancer 96 (2007) 1329-1334
48. Shastri Y., and Stein J. New faecal tests for colorectal cancer screening: is tumour pyruvate kinase M2 on of the options?. British Journal of Cancer 97 (2007) 1595-1596
49. Meucci G, D'Inca R, Maieron R, Orzes N, Vecchi M, Visentini D. et al. Diagnostic value of faecal calprotectin in unselected outpatients referred for colonoscopy: a multicenter prospective study. Digestive and Liver Disease. doi:10.1016/j.dld.2009.07.002. in press.
50. Hoff G., Grotmol T., Thiis-Evensen E., Bretthauer M., Gondal G., and Vatn M. Testing for faecal calprotectin (PhiCal) in the Norwegian colorectal cancer prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (Flexsure OBT). Gut 53 (2004) 1329-1333